Concepedia
3
Publications
109
Citations
H-Index
2018
Active since
Affiliations
Rutgers, The State University of New Jersey(Current)
Johnson University
Memorial Sloan Kettering Cancer Center
Aditya Thandoni is an author at Rutgers, The State University of New Jersey.
Publications per year
2018–2023
VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells
Atif J. Khan, Sarah M. Misenko, Aditya Thandoni et al. · Oncotarget · 2018 · 51 citations · Full text
The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, <i>in vitro</i> and <i>in vivo</i>
Atif J. Khan, Stephanie LaCava, Monal Mehta et al. · Oncotarget · 2019 · 31 citations · Full text
Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer
Sachin R. Jhawar, Shang-Jui Wang, Aditya Thandoni et al. · Journal for ImmunoTherapy of Cancer · 2023 · 27 citations · Full text
Rows per page
1–3 of 3